Pfizer Inc (PFE) stock
PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Nov 3, 2026Score 8/3047% above fair value
$29.45+0.09 (+0.31%)
Close on Nov 11, 2026Market cap $167.86BP/E 42.1Yield 5.84%
Pfizer profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Pfizer's profit margin for the twelve months ending Sep 27, 2026 was 6.3%. For fiscal 2025 it was 12.4%, against 12.6% the year before. The highest annual figure on record is 42.7% in fiscal 2013.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 12.4% | −0.2 |
| FY2024 | Dec 31, 2024 | 12.6% | +9.1 |
| FY2023 | Dec 31, 2023 | 3.6% | −27.4 |
| FY2022 | Dec 31, 2022 | 31.0% | +4.0 |
| FY2021 | Dec 31, 2021 | 27.0% | +5.0 |
| FY2020 | Dec 31, 2020 | 22.0% | −17.2 |
| FY2019 | Dec 31, 2019 | 39.2% | +11.9 |
| FY2018 | Dec 31, 2018 | 27.3% | −13.2 |
| FY2017 | Dec 31, 2017 | 40.6% | +26.9 |
| FY2016 | Dec 31, 2016 | 13.7% | −0.6 |
| FY2015 | Dec 31, 2015 | 14.2% | −4.2 |
| FY2014 | Dec 31, 2014 | 18.4% | −24.2 |
| FY2013 | Dec 31, 2013 | 42.7% | +16.0 |
| FY2012 | Dec 31, 2012 | 26.7% | +10.3 |
| FY2011 | Dec 31, 2011 | 16.4% | +3.7 |
| FY2010 | Dec 31, 2010 | 12.7% | −4.9 |
| FY2009 | Dec 31, 2009 | 17.5% | +0.7 |
| FY2008 | Dec 31, 2008 | 16.8% | −0.0 |
| FY2007 | Dec 31, 2007 | 16.8% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 27, 2026 | 19.6% | −1.7 |
| Q2 FY2026 | Jun 28, 2026 | -1.6% | −21.5 |
| Q1 FY2026 | Mar 29, 2026 | 18.6% | −3.0 |
| Q4 FY2025 | Dec 31, 2025 | -9.4% | −11.7 |
| Q3 FY2025 | Sep 28, 2025 | 21.3% | −4.0 |
| Q2 FY2025 | Jun 29, 2025 | 19.9% | +19.6 |
| Q1 FY2025 | Mar 30, 2025 | 21.6% | +0.7 |
| Q4 FY2024 | Dec 31, 2024 | 2.3% | +25.4 |
| Q3 FY2024 | Sep 29, 2024 | 25.2% | +42.9 |
| Q2 FY2024 | Jun 30, 2024 | 0.3% | −17.6 |
| Q1 FY2024 | Mar 31, 2024 | 20.9% | −9.0 |
| Q4 FY2023 | Dec 31, 2023 | -23.1% | −43.0 |
| Q3 FY2023 | Oct 1, 2023 | -17.7% | −55.7 |
| Q2 FY2023 | Jul 2, 2023 | 17.9% | −17.8 |
| Q1 FY2023 | Apr 2, 2023 | 30.0% | −0.7 |
| Q4 FY2022 | Dec 31, 2022 | 19.9% | +5.6 |
| Q3 FY2022 | Oct 2, 2022 | 38.0% | +4.1 |
| Q2 FY2022 | Jul 3, 2022 | 35.7% | +6.3 |
| Q1 FY2022 | Apr 3, 2022 | 30.6% | −3.0 |
| Q4 FY2021 | Dec 31, 2021 | 14.2% | +6.8 |
| Q3 FY2021 | Oct 3, 2021 | 33.9% | +19.6 |
| Q2 FY2021 | Jul 4, 2021 | 29.4% | −5.9 |
| Q1 FY2021 | Apr 4, 2021 | 33.6% | +0.3 |
| Q4 FY2020 | Dec 31, 2020 | 7.4% | +39.0 |
| Q3 FY2020 | Sep 27, 2020 | 14.3% | −46.3 |
| Q2 FY2020 | Jun 28, 2020 | 35.4% | −2.7 |
| Q1 FY2020 | Mar 29, 2020 | 33.3% | +3.7 |
| Q4 FY2019 | Dec 31, 2019 | -31.6% | +2.4 |
| Q3 FY2019 | Sep 29, 2019 | 60.6% | +29.6 |
| Q2 FY2019 | Jun 30, 2019 | 38.0% | +9.3 |
| Q1 FY2019 | Mar 31, 2019 | 29.6% | +2.0 |
| Q4 FY2018 | Dec 31, 2018 | -34.0% | −123.6 |
| Q3 FY2018 | Sep 30, 2018 | 30.9% | +9.4 |
| Q2 FY2018 | Jul 1, 2018 | 28.8% | +4.9 |
| Q1 FY2018 | Apr 1, 2018 | 27.6% | +3.2 |
| Q4 FY2017 | Dec 31, 2017 | 89.6% | +83.9 |
| Q3 FY2017 | Oct 1, 2017 | 21.6% | – |
| Q2 FY2017 | Jul 2, 2017 | 23.8% | – |
| Q1 FY2017 | Apr 2, 2017 | 24.4% | – |
| Q4 FY2016 | Dec 31, 2016 | 5.7% | – |
See a number that looks wrong?